If the biggest medical device developers are having a hard time of it, they are not the only ones. Among the medium sized medtech companies, there was again only one – the blood collection specialist Haemonetics – that managed to keep its head above water in terms of share price moves across the first half.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,